[go: up one dir, main page]

TR200402720T4 - Metalloproteaz inhibitörleri olarak 2-(4-piridinil)-benzofüran'lar - Google Patents

Metalloproteaz inhibitörleri olarak 2-(4-piridinil)-benzofüran'lar

Info

Publication number
TR200402720T4
TR200402720T4 TR2004/02720T TR200402720T TR200402720T4 TR 200402720 T4 TR200402720 T4 TR 200402720T4 TR 2004/02720 T TR2004/02720 T TR 2004/02720T TR 200402720 T TR200402720 T TR 200402720T TR 200402720 T4 TR200402720 T4 TR 200402720T4
Authority
TR
Turkey
Prior art keywords
benzofurans
pyridinyl
metalloprotease inhibitors
relates
isomers
Prior art date
Application number
TR2004/02720T
Other languages
English (en)
Inventor
De Nanteuil Guillaume
Benoist Alain
Pastoureau Philippe
Sabatini Massimo
Hickman John
Pierre Alain
Tucker Gordon
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of TR200402720T4 publication Critical patent/TR200402720T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut bulus, yeni metalloproteaz inhibitörlerine, özellikle formül (I) bilesiklerine, bunlarin izomerlerine, N-oksitlere ve farmasötik açidan kabul edilebilir bir asit ve baz ile olan ekleme tuzlarina iliskindir. Bulusa ayrica bunlarin hazirlanma yöntemlerine ve bunlari içeren farmasötik bilesimlere iliskindir.
TR2004/02720T 2000-12-22 2001-12-21 Metalloproteaz inhibitörleri olarak 2-(4-piridinil)-benzofüran'lar TR200402720T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0016826A FR2818643B1 (fr) 2000-12-22 2000-12-22 Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques que les contiennent

Publications (1)

Publication Number Publication Date
TR200402720T4 true TR200402720T4 (tr) 2004-11-22

Family

ID=8858043

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02720T TR200402720T4 (tr) 2000-12-22 2001-12-21 Metalloproteaz inhibitörleri olarak 2-(4-piridinil)-benzofüran'lar

Country Status (25)

Country Link
US (1) US6686348B2 (tr)
EP (1) EP1217002B1 (tr)
JP (1) JP2002226479A (tr)
KR (1) KR100445388B1 (tr)
CN (1) CN1159318C (tr)
AR (1) AR035409A1 (tr)
AT (1) ATE277053T1 (tr)
AU (1) AU783908B2 (tr)
BR (1) BR0106248A (tr)
CA (1) CA2364864C (tr)
DE (1) DE60105746T2 (tr)
DK (1) DK1217002T3 (tr)
EA (1) EA004254B1 (tr)
ES (1) ES2227096T3 (tr)
FR (1) FR2818643B1 (tr)
HK (1) HK1047100B (tr)
HU (1) HUP0105410A3 (tr)
MX (1) MXPA01012896A (tr)
NO (1) NO321490B1 (tr)
NZ (1) NZ516338A (tr)
PL (1) PL351301A1 (tr)
PT (1) PT1217002E (tr)
SI (1) SI1217002T1 (tr)
TR (1) TR200402720T4 (tr)
ZA (1) ZA200110517B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078541B2 (en) * 2002-02-07 2006-07-18 Galileo Pharmaceuticals, Inc. Benzofuran derivatives
US6653346B1 (en) * 2002-02-07 2003-11-25 Galileo Pharmaceuticals, Inc. Cytoprotective benzofuran derivatives
US8088737B2 (en) 2003-04-04 2012-01-03 Incyte Corporation Compositions, methods and kits relating to Her-2 cleavage
DE102005002500A1 (de) * 2005-01-19 2006-07-27 Sanofi-Aventis Deutschland Gmbh Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen
WO2006081471A2 (en) 2005-01-28 2006-08-03 The Regents Of The University Of California Systems and methods using nuclear magnetic resonance (nmr) spectroscopy to evaluate pain and degenerative properties of tissue
US8825131B2 (en) 2009-10-14 2014-09-02 Nocimed, Llc MR spectroscopy system and method for diagnosing painful and non-painful intervertebral discs
US8761860B2 (en) 2009-10-14 2014-06-24 Nocimed, Llc MR spectroscopy system and method for diagnosing painful and non-painful intervertebral discs
US8796306B2 (en) 2010-06-23 2014-08-05 Sumitomo Chemical Company, Limited Noxious arthropod controlling composition and heterocyclic compound
US9280718B2 (en) 2010-11-24 2016-03-08 Nocimed, Llc Systems and methods for automated voxelation of regions of interest for magnetic resonance spectroscopy
US8965094B2 (en) 2012-04-14 2015-02-24 Nocimed, Llc Magnetic resonance spectroscopy pulse sequence, acquisition, and processing system and method
EP4289347A3 (en) 2016-06-19 2024-03-06 Aclarion, Inc. Magnetic resonance spectroscopy system and method for diagnosing pain or infection associated with propionic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5880154A (ja) * 1981-11-06 1983-05-14 Matsushita Electric Ind Co Ltd テ−プ移送装置
JPH08157463A (ja) * 1994-11-30 1996-06-18 Canon Inc 液晶性化合物、それを含有する液晶組成物、それを有する液晶素子及びそれらを用いた表示方法、液晶装置
FR2748026B1 (fr) * 1996-04-26 1998-06-05 Adir Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL331920A1 (en) * 1996-08-28 1999-08-16 Procter & Gamble Spirocyclic inhibitors of metaloproteases

Also Published As

Publication number Publication date
FR2818643A1 (fr) 2002-06-28
EA004254B1 (ru) 2004-02-26
FR2818643B1 (fr) 2003-02-07
ZA200110517B (en) 2002-07-11
HUP0105410A3 (en) 2004-01-28
DE60105746T2 (de) 2005-10-06
HK1047100A1 (en) 2003-02-07
EA200101230A1 (ru) 2002-06-27
HU0105410D0 (en) 2002-02-28
AU783908B2 (en) 2005-12-22
EP1217002A1 (fr) 2002-06-26
EP1217002B1 (fr) 2004-09-22
HK1047100B (zh) 2005-01-07
DE60105746D1 (de) 2004-10-28
KR100445388B1 (ko) 2004-08-25
US6686348B2 (en) 2004-02-03
BR0106248A (pt) 2002-08-20
CA2364864A1 (fr) 2002-06-22
CA2364864C (fr) 2006-07-18
MXPA01012896A (es) 2003-07-21
AU9744201A (en) 2002-06-27
PT1217002E (pt) 2004-11-30
DK1217002T3 (da) 2005-01-24
CN1159318C (zh) 2004-07-28
KR20020051886A (ko) 2002-06-29
PL351301A1 (en) 2002-07-01
ATE277053T1 (de) 2004-10-15
JP2002226479A (ja) 2002-08-14
HUP0105410A2 (en) 2002-08-28
NO20016177L (no) 2002-06-24
NO321490B1 (no) 2006-05-15
SI1217002T1 (en) 2004-12-31
CN1359900A (zh) 2002-07-24
AR035409A1 (es) 2004-05-26
NO20016177D0 (no) 2001-12-18
NZ516338A (en) 2003-05-30
US20020137744A1 (en) 2002-09-26
ES2227096T3 (es) 2005-04-01

Similar Documents

Publication Publication Date Title
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
EP1248612A4 (en) NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS
NL300877I2 (nl) obeticholzuur
SE0202463D0 (sv) Novel compounds
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
TR200103186T2 (tr) MEK enzimlerinin inhibitörleri olarak kinolin türevleri
CO5271675A1 (es) Derivados de decahidro-isoquinolinas, proceso para su preparacion, composicion y compuestos farmaceuticos que los contienen
TR199900486T2 (tr) Aziniloksi ve fenoksi-diaril-karbonasit türevleri.
TR200402720T4 (tr) Metalloproteaz inhibitörleri olarak 2-(4-piridinil)-benzofüran'lar
MXPA02012910A (es) Amidas de acidobifenilcarboxilico, su preparacion y su uso como medicinas.
NO20052520D0 (no) Nye sulfamider
EA200600100A1 (ru) Производные никотинамида, полезные в качестве ингибиторов pde4
ATE253359T1 (de) Antithrombotische mittel
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
BRPI0411218A (pt) formulações alvejantes fluorescentes estáveis em estocagem
ATE286395T1 (de) Antithrombotische mittel
DK1347965T3 (da) Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf
DE60110233D1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
TR200400592T4 (tr) Karbanat ve tiyokarbamat podofilotoksin türevleri, bunları hazırlama yöntemi ve bunları ve içeren farmasötik bileşimler
DE60227113D1 (de) Kondensierte camptothecine als antitumormittel
NO20004075L (no) Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister
TR200302002T4 (tr) Heterosikloalkilbenzosiklobütan ve heteroarilbenzosiklobütan türevleri ve bunların serotonin ve noradrenalin'in geri kapılmasında inhibitör olarak kullanılmaları